New Funding Awards for Translational Research in Heart, Lung, Blood and Sleep Disorders
The University of California Center for Accelerated Innovation (UC CAI), a collaboration of the five UC medical campuses focused on accelerating the translation of UC discoveries to benefit patients with heart, lung and blood diseases, invites applications from UC investigators who propose to advance highly innovative early-stage drugs, devices and diagnostics toward commercialization. Learn more at http://uccai.ctsi.ucla.edu/
- Award: Up to $200,000 for two years. Includes project management and product development mentoring
- Eligibility: All faculty at UC Davis, Irvine, Los Angeles, San Diego and San Francisco. Postdoctoral scholars are eligible to submit as Co-PI with a faculty PI
- Due Date: Online submission begins Monday, December 2, 2013. Pre-applications are required and must be submitted by Friday, December 20. Successful applicants will be invited to submit full applications
- View the RFA visit http://uccai.ctsi.ucla.edu/
Questions about the awards? Contact Ruben Rathnasingham, PhD, Associate Director, Early Translational Research program, UCSF CTSI: [email protected]
UC CAI is administered from UCLA and is supported by the National Institute of Heart, Lung and Blood Diseases. It is one of three such centers in the U.S.
Thank your for your participation and for sharing this opportunity with your colleagues.
Sincerely,
June Lee, MD, FACCP, UCSF - UC CAI Site Leader
Shaun Coughlin, MD, PhD, UCSF - UC CAI Site Leader
Posted by John Daigre